LABD vs. HIBS
Compare and contrast key facts about Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P 500 High Beta Bear 3X Shares (HIBS).
LABD and HIBS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABD is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (-300%). It was launched on May 28, 2015. HIBS is a passively managed fund by Direxion that tracks the performance of the S&P 500® High Beta Index. It was launched on Nov 7, 2019. Both LABD and HIBS are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
LABD vs. HIBS - Performance Comparison
Loading graphics...
LABD vs. HIBS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -22.25% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -38.21% |
HIBS Direxion Daily S&P 500 High Beta Bear 3X Shares | -5.70% | -72.44% | -26.60% | -62.94% | -7.59% | -75.27% | -91.59% | -19.45% |
Returns By Period
In the year-to-date period, LABD achieves a -22.25% return, which is significantly lower than HIBS's -5.70% return.
LABD
- 1D
- -22.42%
- 1M
- -7.39%
- YTD
- -22.25%
- 6M
- -59.03%
- 1Y
- -82.24%
- 3Y*
- -55.49%
- 5Y*
- -38.61%
- 10Y*
- -57.45%
HIBS
- 1D
- -13.00%
- 1M
- 13.98%
- YTD
- -5.70%
- 6M
- -25.96%
- 1Y
- -80.66%
- 3Y*
- -52.31%
- 5Y*
- -48.51%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABD vs. HIBS - Expense Ratio Comparison
Both LABD and HIBS have an expense ratio of 1.06%.
Return for Risk
LABD vs. HIBS — Risk / Return Rank
LABD
HIBS
LABD vs. HIBS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P 500 High Beta Bear 3X Shares (HIBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | HIBS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.96 | -0.89 | -0.06 |
Sortino ratioReturn per unit of downside risk | -2.04 | -1.76 | -0.29 |
Omega ratioGain probability vs. loss probability | 0.77 | 0.77 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | -0.91 | -0.90 | -0.01 |
Martin ratioReturn relative to average drawdown | -1.17 | -1.03 | -0.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LABD | HIBS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.96 | -0.89 | -0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.40 | -0.59 | +0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.60 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | -0.69 | +0.15 |
Correlation
The correlation between LABD and HIBS is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LABD vs. HIBS - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 5.82%, more than HIBS's 5.02% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 5.82% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
HIBS Direxion Daily S&P 500 High Beta Bear 3X Shares | 5.02% | 8.42% | 5.34% | 6.49% | 0.04% | 0.00% | 0.92% | 0.13% | 0.00% |
Drawdowns
LABD vs. HIBS - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, roughly equal to the maximum HIBS drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for LABD and HIBS.
Loading graphics...
Drawdown Indicators
| LABD | HIBS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -99.96% | -0.03% |
Max Drawdown (1Y)Largest decline over 1 year | -88.09% | -88.93% | +0.84% |
Max Drawdown (5Y)Largest decline over 5 years | -97.73% | -97.19% | -0.54% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | — | — |
Current DrawdownCurrent decline from peak | -99.99% | -99.96% | -0.03% |
Average DrawdownAverage peak-to-trough decline | -90.78% | -92.95% | +2.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 68.46% | 77.89% | -9.43% |
Volatility
LABD vs. HIBS - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 36.88% compared to Direxion Daily S&P 500 High Beta Bear 3X Shares (HIBS) at 28.28%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than HIBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LABD | HIBS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 36.88% | 28.28% | +8.60% |
Volatility (6M)Calculated over the trailing 6-month period | 59.06% | 54.12% | +4.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.11% | 90.42% | -3.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.40% | 82.14% | +14.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.40% | 95.39% | +1.01% |